PlainPharmaWatch

CMS Open Payments · Program Year 2024

Servier Pharmaceuticals LLC

Servier Pharmaceuticals LLC reported $1,483,387.62 in payments to 5,634 physicians and teaching hospitals across 5,634 transactions.

See the rankings → How this is sourced
$1.5M
Total payments
5,634
Transactions
5,634
Recipients
+$425.4K
General Payments vs PY2023

Servier Pharmaceuticals LLC reported $1,483,387.62 in payments to 5,634 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #530 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $263.29 per recipient across 5 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Servier Pharmaceuticals LLC pairs above-median payment volume with an unusually diversified payment pattern across a wide recipient base.

#530
of 1,925 companies
0.0%
of all US industry payments
0.1%
paid to its single top recipient
5
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

Servier Pharmaceuticals LLC's CMS-reported General Payments increased by $425.4K (+40.2%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2022: SERVIER PHARMACEUTICALS LLCPY2023: SERVIER PHARMACEUTICALS LLCPY2024: SERVIER PHARMACEUTICALS LLC. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$1.1MPY2024$1.5M
PY2023
$1,057,938.21
PY2024
$1,483,387.62

How Servier Pharmaceuticals LLC ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Servier Pharmaceuticals LLC's total vs. every reporting company

CMS Open Payments, Program Year 2024

$1,483,388 Top 27% higher than 73% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). Below this entry. $242,294–$752,621: 270 reporting companies (14%). Below this entry. $752,621–$2,337,813: 263 reporting companies (14%). This entry sits in this band. $2,337,813–$7,261,783: 200 reporting companies (10%). Above this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Servier Pharmaceuticals LLC

Servier Pharmaceuticals LLC ranks #530 out of 1,925 companies in the CMS Open Payments database for Program Year 2024, a comparatively small 0.0% slice of all industry payments reported nationwide for the year. The underlying total is $1,483,387.62 across 5,634 transactions to 5,634 physicians and teaching hospitals - $263.29 per transaction and $263.29 per recipient on average.

The 5-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Consulting Fee" at $888.6K, accounting for 59.9% of the company's reported total and 259 transactions.

General Payment Breakdown by Type

Across 5 types of general payments, Servier Pharmaceuticals LLC's largest category was "Consulting Fee" at $888.6K - 59.9% of the company's reported total.

How Servier Pharmaceuticals LLC divides its payments

General-payment categories, ordered by reported total

1. Consulting Fee$888.6K2. Space Rental or Facility …$235.0K3. Food and Beverage$168.4K4. Compensation for Services…$100.5K5. Travel and Lodging$91.0K
Payment Type Amount Transactions
Consulting Fee $888.6K 259
Space Rental or Facility Fees $235.0K 24
Food and Beverage $168.4K 5,016
Compensation for Services Other Than Consulting $100.5K 56
Travel and Lodging $91.0K 279

Recipient Concentration in General Payments

The five largest recipient relationships account for $253,169.67 (17.1%) of $1,483,387.62 in this company's General Payments records across 3,464 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Servier Pharmaceuticals LLC

The five named recipients with the highest reported General Payments from this company

Moffitt Cancer Center$159.8KRami Komrokji$25.7KHarry Erba$23.6KYoshie Umemura$23.3KRimas Lukas$20.8K
  1. 1

    Moffitt Cancer Center

    $159,836.20 across 9 reported transactions

  2. 2

    Rami Komrokji

    $25,729.67 across 16 reported transactions

  3. 3

    Harry Erba

    $23,583.10 across 20 reported transactions

  4. 4

    Yoshie Umemura

    $23,250.91 across 15 reported transactions

  5. 5

    Rimas Lukas

    $20,769.79 across 12 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $263.29. Average per recipient: $263.29.

Total Amount

$1,483,387.62

Avg per Transaction

$263.29

Avg per Recipient

$263.29

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Servier Pharmaceuticals LLC Share

0.0%

#530 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Servier Pharmaceuticals LLC

Adaptive Biotechnologies Corporation

$1.5M 3,663 recipients

Cook Research Incorporated

$1.5M 55 recipients

FUJIFILM Healthcare Americas Corporation

$1.5M 993 recipients

CardioFocus, Inc.

$1.5M 202 recipients

Artivion, Inc.

$1.5M 1,638 recipients

Vital Connect, Inc

$1.5M 832 recipients

Frequently Asked Questions

How much did Servier Pharmaceuticals LLC pay to physicians and hospitals in 2024? ▾
In Program Year 2024, CMS Open Payments recorded $1,483,387.62 from Servier Pharmaceuticals LLC to physicians and hospitals across 5,634 transactions - 0.0% of all industry payments reported that year.
How many physicians received payments from Servier Pharmaceuticals LLC? ▾
Averaging $263.29 per recipient, Servier Pharmaceuticals LLC's 2024 payments reached 5,634 physicians and teaching hospitals.
What types of payments did Servier Pharmaceuticals LLC make? ▾
5 categories of general payment make up Servier Pharmaceuticals LLC's reported activity, including consulting, meals, travel, and similar types. The largest general-payment category was "Consulting Fee" at $888.6K, representing 59.9% of the company's reported total.
How does Servier Pharmaceuticals LLC rank among pharmaceutical companies? ▾
Out of 1,925 companies in the CMS Open Payments database for 2024, Servier Pharmaceuticals LLC ranks #530 by total payment amount.
What is the average payment size from Servier Pharmaceuticals LLC? ▾
The average transaction from Servier Pharmaceuticals LLC was $263.29 in 2024. The company made 5,634 total transactions to 5,634 recipients.
Where does the payment data for Servier Pharmaceuticals LLC come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Servier Pharmaceuticals LLC's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.